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eAppendix. Supplementary Methods 
We utilized serum samples that were prospectively collected from patients who presented to the 
Barnes Jewish Hospital in Saint Louis, MO with symptoms suggestive of COVID-19 illness and 
were confirmed to have SARS-CoV-2 infection with nasopharyngeal swabs. Testosterone, 
estradiol, and IGF-1 were measured by liquid chromatography- mass spectrometry at the time of 
presentation to the hospital (baseline or day 0) and at days 3, 7, 14 and 28 after admission (if the 
patient remained hospitalized).  
 
Hormone assays:  
Owing to limited sample volumes available, assays for total testosterone, estradiol, and IGF-1 
were performed following dilution into charcoal stripped serum as follows: 
Testosterone (females): 1 part sample to 2 parts stripped serum 
Testosterone (males):  1 part sample to 3 parts stripped serum 
IGF-1 (both sexes): 1 part sample to 1 part stripped serum 
Estradiol (both sexes): 1 part sample to 1 part stripped serum 
Validation experiments have documented that such dilutions yield reproducible, accurate 




Total testosterone was measured by liquid chromatography tandem mass spectrometry (LC-
MS/MS)1. The method is linear from 205 to 2000 ng/dL with an analytical sensitivity (Limit of 
quantfication) set at a coefficient of variation (CV) of ≤20%, is 1.0 ng/dl.  Intra-assay and total 
CVs across four quality control concentrations were less than 10%. The reference intervals for 
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total testosterone for this assay were 250-1100 ng/dL in adult males 2 and 2-45 ng/dl in adult 
females. The performing laboratory is certified by Clinical Laboratory Improvement 
Amendments and is a participant in the Hormone Standardization program of the Centers for 
Disease Control and Prevention. 
 
Estradiol 
LC-MS/MS methodology was also used to measure total estradiol. The method was similar to 
that previously described 3, with some improvements After adding 300 µL of ethanol spiked with 
internal standards (17β-Estradiol-2,3,4-13C3) to 200 µL of patient serum, the mixture was 
incubated in an ice slurry for 30 minutes before centrifugation. 50 µL of the supernatant was 
injected onto a multiplex High Performance Liquid Chromatography (HPLC) system equipped 
with an online turbo flow extraction system (Cohesive Technologies Inc.; Franklin, MA, part of 
Thermo Fisher Scientific) for further clean up and separation from the matrix. The online 
extraction and HPLC columns were Phenomenex Strata C18-E (70 um, 50x1.0 mm; P/N 00B-
S001-A0) and Phenomenex Biphenyl (2.6 um, 100Å, 50x3.0 mm; P/N AF0-5727) respectively.  
Estradiol and its internal standard were detected by a triple quadrupole mass spectrometer (Sciex 
6500+ Framingham, MA) using H-ESI source and operating in Multiple Reaction Monitoring 
(MRM) mode. The MRM transitions were (m/z) 271.17 to 143.05 and 145.05 for Estradiol and 
274.18 to 148.00 and 186.05 for the Internal Standard. The ratio of the analyte response relative 
to that of the internal standard were used to build a calibration curve and to quantify Estradiol in 
patient samples. The Inter assay precision (CV) of the assay is 4.06% at 20 pg/mL of, 1.42% at 
200 pg/mL, and 1.88% at 800 pg/mL. The LOQ for estradiol in this assay is 2 pg/mL. The 
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reference range is ≤29 pg/mL for men, 39-440 pg/mL for premenopausal women and ≤10 pg/mL 
for postmenopausal women.  
 
IGF-1 measurements 
IGF-1 was measured by highly accurate LC-MS method similar to the method described 
previously.4 100 μL aliquots of patient sera were mixed with 10 μL of internal standard (15N-
labeled IGF-1, ProSpec) and 400 μL of acidified ethanol solution (87.5% EtOH, 12.5% 1 N HCl) 
and mixed vigorously. After incubating at room temperature for 30 min, and centrifugation, 350 
μL of supernatant was mixed with 60 μL of 1.5 M Tris base. The samples were cooled for 60 
min at -20°C and centrifuged again to remove additional protein precipitate. The IGF-1 and its 
internal standard were separated further from matrix using a multiplex high performance liquid 
chromatography (HPLC) system (Aria TLX-4) equipped with an on-line extraction (Thermo 
Scientific, San Jose, CA). The extraction column was a Phenomenex Monolithic Onyx C18 
Guard Cartridge; the analytical column was a Phenomenex Kinetex C18 50 × 4.6 mm, 100 Å 
pore size. A Thermo Scientific Q Exactive Focus Hybrid Quadrupole-Orbitrap mass 
spectrometer (Thermo Scientific, San Jose, CA) was used as the detection system equipped with 
heated electrospray ionization (HESI) source and operating in positive All Ion Fragmentation 
(AIF) mode.  After IGF-1 quantitation, the chromatograms were then examined for the presence 
of variants. No variant was found in this study. 
The inter assay precision (CV) of the IGF-1 assay is 8.79% at 40 ng/mL, 6.43% at 177 
ng/mL, and 5.97% at 358 ng/mL. The LOQ for IGF-1 assay is 8 ng/mL. The reference ranges of 
IGF-1 vary by age and gender and have been described previously5. 
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Cytokine Quantification: Plasma obtained from subjects was frozen at -80°C and subsequently 
analyzed using a human magnetic cytokine panel providing parallel measurement of 35 
cytokines (ThermoFisher). These are Interleukin (IL)-1α, 1β, 2-10, 12, 13, 15, 17A, 17F and 22, 
IL-1 receptor antagonist (IL-1RA), IL-2R, Fibroblast growth factor (FGF)-basic, Tumor necrosis 
factor (TNF)-α, Granulocyte colony-stimulating factor (G-CSF) and Granulocyte-macrophage 
colony-stimulating factor (GM-CSF), RANTES (Regulated on Activation, Normal T Cell 
Expressed and Secreted), Eotaxin, Macrophage Inflammatory Proteins (MIP)-1α and 1β, 
monocyte chemoattractant protein-1 (MCP-1), Epidermal growth factor (EGF), hepatocyte 
growth factor (HGF), Vascular endothelial growth factor (VEGF), Interferon (IFN)-α and γ, 
interferon-γ-inducible protein 10 (IP-10) and monokine induced by gamma interferon (MIG) . 
The assay was performed according to the manufacturer’s instructions with each subject sample 
performed in duplicate and then analyzed on a Luminex FLEXMAP 3D instrument. 
 
PBMC sorting and RNA sequencing 
Cryopreserved peripheral blood mononuclear cells (PBMCs) from COVID patients were thawed 
and washed with HBSS with 2mM EDTA and 0.04% LPS-free BSA. These PBMCs were then 
blocked with 5% goat serum and stained on ice with anti-CD14-APC/Cy7, anti-CD16-PE/Cy7, 
anti-CD15 PerCP/Cy5.5, and anti-CD56-Alexa Fluor 700 for 30 minutes and re-suspended in the 
aforementioned HBSS buffer. Dead cells were excluded based on positive Helix NPTM Green 
staining. The cells were then sorted straight into Trizol by FACS Aria II. Total RNA was isolated 
as per Trizol protocol. RNA of each sample was sequenced at the Genome Technology Access 
Center of the McDonnell Genome Institute at Washington University in St. Louis. Total RNA 
integrity was determined using Agilent Bioanalyzer or 4200 Tapestation. Library preparation 
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was performed with 10ng of total RNA with a Bioanalyzer RIN score greater than 8.0. ds-cDNA 
was prepared using the SMARTer Ultra Low RNA kit for Illumina Sequencing (Takara-
Clontech) per manufacturer's protocol. cDNA was fragmented using a Covaris E220 sonicator 
using peak incident power 18, duty factor 20%, cycles per burst 50 for 120 seconds. cDNA was 
blunt ended, had an A base added to the 3' ends, and then had Illumina sequencing adapters 
ligated to the ends. Ligated fragments were then amplified for 12-15 cycles using primers 
incorporating unique dual index tags. Fragments were sequenced on an Illumina NovaSeq-6000 
using paired end reads extending 150 bases at the Genome Technology Access Center of the 
McDonnell Genome Institute at Washington University in St. Louis. 
Basecalls and demultiplexing were performed with Illumina’s bcl2fastq software and a 
custom python demultiplexing program with a maximum of one mismatch in the indexing read.  
RNA-seq reads were then aligned to the Ensembl release 76 top-level assembly of the human 
genome (GRCh38) along with the SARS-CoV-2 reference genome with STAR version 2.0.4b6 
with the parameters --outStd BAM_Unsorted   --outMultimapperOrder Random   --outSAMtype 
BAM   Unsorted      --outSAMunmapped None      --outSAMmapqUnique 60   --
outFilterScoreMinOverLread 0   --outFilterMatchNmin 20   --outFilterMatchNminOverLread 0   
--outFilterMismatchNoverLmax 0.1   --clip3pAdapterSeq 
AGATCGGAAGAGCGGTTCAGCAGGAATGCCGAG   
AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA. Gene counts were derived from the 
number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.57 to 
Ensembl and SARS-CoV-2 gene models.  Sequencing performance was assessed for the total 
number of aligned reads, total number of uniquely aligned reads, and features detected.  
Differential expression analysis to determine genes that differed with severe disease for each cell 
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type and both male and females was performed using DESeq2 (v1.24)8. Genes without at least 
10 read counts across all samples were removed prior to analysis. Gene Set Enrichment Analysis 
(v4.0.3)9 was performed using the GSEAPreranked tool against the Hallmark gene set (v7.2).  




We assessed the relation of testosterone, estradiol, and IGF-1 concentrations during the 
hospitalization with COVID severity, ICU and ventilator use, mortality and inflammatory 
cytokines using univariate and multivariate regression and mixed model analyses. These models 
addressed missing data values by maximum likelihood, under the data missing at random 
assumption.  Sensitivity analyses were performed to evaluate this assumption. Based on these 
analyses, missing at random assumption was deemed reasonable. The comparisons were adjusted 
for age, BMI, race, smoking and co-morbidities at baseline (Charlson Comorbidity Index, CCI). 
CCI is a validated method to determine significant medical comorbidity.  It considers 17 
common medical conditions that predict one-year mortality.  These include myocardial 
infarction, heart failure, peripheral arterial disease, cerebrovascular disease, dementia, chronic 
pulmonary disease, connective tissue disease, ulcer disease, liver disease, diabetes (including 
diabetes with end organ damage), hemiplegia, renal disease, leukemia, lymphoma, solid tumors, 
and AIDS. Medical diagnoses are weighted for severity and summed to provide a weighted index 
of medical comorbidity with total scores ranging from 0-33. 
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eTable 1. Baseline Characteristics, Hormone Concentrations, and Hospital Outcomes in Men 
and Women 
 Males (N=90) Females (N=62) P 
Age (years) 64±14 61±18 0.33 
BMI (kg/m2) 27.7±6.8 33±8.8 <0.001 
Charlson comorbidity 
index 
3 [1, 4] 2 [1, 3] 0.046 
Severe COVID 71% 60% 0.14 
ICU 59% 47% 0.14 
ventilator 27% 21% 0.42 
Mortality 28% 19% 0.23 
Testosterone (ng/dl) 79 [38, 181] 12 [1, 21] <0.001 
Estradiol (pg/ml) 15 [10, 22] 15 [3, 47] 0.34 
IGF-1 (ng/ml) 90 [62, 126] 106 [62, 127] 0.90 
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eTable 2. Serum Estradiol Concentration by Intensive Care Unit Admission, Ventilator Use, and 
Mortality in Men 
  Day 0 Day 3 Day 7 Day 14 Day 28 
ICU Yes 
(N=53) 
15 [11, 25] 13 [7, 26] 13 [7, 20] 18 [10, 23] 13 [10, 26] 





22 [14, 31] 10 [6, 31] 11 [4, 21] 19 [12, 23] 13 [12, 33] 
No (N= 
66) 
13 [10, 19] 13 [9, 19] 13 [11, 21] 9 [8, 17] 13 [12, 33]  
Mortality Deceased 
(N= 25) 
18 [12, 27] 16 [9, 33] 16 [2, 30] 15 [9, 23] No data 
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eTable 3. Serum Insulinlike Growth Factor 1 Concentration by Intensive Care Unit Admission, 
Ventilator Use, and Mortality in Men 













































78 [59, 98] 65 [40, 99] 69 [53, 
119] 
No data No data 
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eTable 4. Serial Hormone Concentration in Women With and Without Severe COVID-19 
 Severe 
COVID 
Day 0 Day 3 Day 7 
Testosterone (ng/dl) 
Yes 10 [1, 21] 9 [3, 32] 15 [5, 24] 
No 14 [1, 24] 10 [5, 13] No data 
Estradiol (pg/ml) 
Yes  10 [4, 50] 20 [10, 31] 16 [8, 47] 
No  20 [2, 45] 13 [8, 42] No data 
IGF-1 (ng/ml) 
Yes  92 [52, 128] 70 [40, 91] 65 [43, 105] 
No  108 [66, 139] 87 [55, 151] No data 
Estradiol/Testosterone 
(%) 
Yes  16 [6, 58] 23 [11, 120] 19 [5, 16] 
No 29 [21, 40] 20 [18, 80] No data 
#p<0.05 for comparison with day 0 
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eTable 5. Serum Estradiol Concentration by Intensive Care Unit Admission, Ventilator Use, and 
Mortality in Women 
  Day 0 Day 3 Day 7 
ICU Yes (N=29) 10 [2, 48] 20 [11, 30] 16 [8, 52] 
No (N=33) 20 [5, 45] 16 [10, 38] 29 [17, 34] 
ventilator Yes (N=13) 47 [5, 57]* 30 [23, 68]# 16 [10, 103] 
No (N=49) 10 [4, 28] 14 [9, 25] 21 [8, 32] 
Mortality Deceased 
(N=12) 
8 [2, 56] 22 [15, 24] 16 [11, 108] 
Alive (N=50) 16 [5, 45] 15 [9, 35] 21 [8, 32] 
*p=0.02 as compared to women without ventilator use, adjusted for group differences in age, 
BMI, CCI, smoking status and race. 
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eTable 6: Serum Testosterone Concentrations by Intensive Care Unit Admission, Ventilator 
Usage and Mortality in Women 
  Day 0 Day 3 Day 7 
ICU Yes (N=29) 10 [4, 21] 8 [3, 22] 15 [4, 24] 
No (N=33) 14 [1, 23] 10 [5, 16] 14 [11, 20] 
ventilator Yes (N=13) 19 [8, 39] 29 [8, 47] 18 [8, 35] 
No (N=49) 10 [1, 20] 7 [3, 14] 14 [8, 17] 
Mortality Deceased (N=12) 15 [4, 39] 9 [1, 45] 35 [4, 39] 
Alive (N=50) 11 [1, 20] 10 [4, 17] 14 [8, 17] 
*p<0.05 as compared to women with comparator group (no ICU stay, no ventilator use or alive), 
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eTable 7.: Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways That 
Are Upregulated in 7 Men in Intensive Care Units Compared With 5 Men With Mild Disease in 
CD14+CD16- Peripheral Blood Mononuclear Cells 
GS 









































































































































































































































































































































































































































































































Pathways shown are based on cutoffs defined as q<0.05  
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eTable 8. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways That 
Are Upregulated in 4 Women in Intensive Care Units Compared With 4 Women With Mild 
Disease in CD14+CD16- Peripheral Blood Mononuclear Cells 
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eTable 9. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways That 
Are Downregulated in 7 Men in Intensive Care Units Compared With 5 Men With Mild Disease 
in CD14+CD16- Peripheral Blood Mononuclear Cells 



























































4401 tags=32%, list=15%, 
signal=37% 
 
Pathways shown are based on cutoffs defined by q<0.05. No pathways were observed to be 
significantly downregulated in Female ICU patients as compared to those with mild disease in in 
CD14+CD16- peripheral blood mononuclear cells.  
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eTable 10. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways 
That Are Upregulated in 7 Men in Intensive Care Units Compared With 5 Men With Mild 
Disease in CD14-CD16+ Peripheral Blood Mononuclear Cells 





































































































































































































































































































































































































































Pathways shown are based on cutoffs defined by q<0.05  
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eTable 11. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways 
That Are Upregulated in 4 Women in Intensive Care Units Compared With 4 Women With Mild 
Disease in CD14-CD16+ Peripheral Blood Mononuclear Cells 
  GS DETAILS 









































































































































































Pathways shown are based on cutoffs defined as q<0.05 
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eTable 12. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways 
That Are Downregulated in 7 Men in Intensive Care Units Compared With 5 Men With Mild 
Disease in CD14-CD16+ Peripheral Blood Mononuclear Cells 



















































































Pathways shown are based on cutoffs defined as q<0.05 
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eTable 13. Gene Set Enrichment Analyses on Hallmark Gene Sets Demonstrating Pathways 
That Are Downregulated in 4 Women in Intensive Care Units Compared With 4 Women With 
Mild Disease in CD14-CD16+ Peripheral Blood Mononuclear Cells 









































































































Pathways shown are based on cutoffs defined as q<0.05  
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* * *
 
eFigure 1. Testosterone Concentrations During Hospital Stay in Male Patients 
Values are median [25th, 75th percentile]. Day 0 includes the 6 patients who were not 
hospitalized. Serum testosterone concentrations were available on days 0, 3, 7, 14 and 28 in 76, 
53, 41, 21 and 12 patients, respectively. * p<0.05 as compared to day 0.  
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eFigure 2. Estradiol Concentrations During Hospital Stay in Male Patients 
Values are median [25th, 75th percentile]. Day 0 includes the 6 patients who were not 
hospitalized. Serum estradiol concentrations were available on days 0, 3, 7, 14 and 28 in 55, 42, 
30, 19 and 11 patients, respectively.  
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eFigure 3. Insulinlike Growth Factor 1 Concentrations During Hospital Stay in Male Patients 
Values are median [25th, 75th percentile]. Day 0 includes the 6 patients who were not 
hospitalized. Serum IGF-1 concentrations were available on days 0, 3, 7, 14 and 28 in 64, 36, 30, 
15 and 10 patients, respectively.  
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eFigure 4. Regression Curve Demonstrating Probability of COVID-19 Severity as Predicted by 
Testosterone 
Includes 95% confidence intervals. After multivariate adjustment for age, BMI, CCI, smoking 
and race. 
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eFigure 5. Regression Curves Demonstrating Probability of Intensive Care Unit Admission, 
Ventilator Usage, or Mortality as Predicted by Testosterone 
After multivariate adjustment for age, BMI, CCI, smoking and race.  
 


















Day 0 Day 7  
eFigure 6. Estradiol Concentrations in Women at Days 0, 3, and 7 
Values are median [25th, 75th percentile]. Estradiol concentrations were available on days 0, 3 
and 7 in 44, 26 and 18 patients, respectively.  
 
 




















Day 3 Day 7  
eFigure 7. Testosterone Concentrations in Women at Days 0, 3, and 7 
Values are median [25th, 75th percentile]. Testosterone concentrations were available on days 0, 3 
and 7 in 56, 30 and 21 patients, respectively.  
 




















eFigure 8. Insulinlike Growth Factor 1 Concentrations in Women at Days 0, 3, and 7 
Values are median [25th, 75th percentile]. IGF-1 concentrations were available on days 0, 3 and 7 
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